255 results about "Proteome" patented technology

This invention discloses a milk protein containing composition comprising: at least one milk protein; at least a first protein; at least a second protein; and at least a linker comprising an amino acid sequence coded by nucleotide sequence which is at least 80% similar to sequences selected from the group consisting of SEQ ID NO: 14, SEQ ID NO: 15, SEQ ID NO: 16, SEQ ID NO: 17, SEQ ID NO: 18, SEQ ID NO: 19, SEQ ID NO: 20, and SEQ ID NO: 21

The invention provides a rapid quantitative analysis method for an outer vesicle proteome, and belongs to the technical field of quantitative analysis of the outer vesicle proteome. According to the rapid quantitative analysis method for the outer vesicle proteome, firstly, a high-quality outer vesicle sample is obtained through low-speed centrifugation, ultra-speed centrifugation and membrane filtration; and obtaining proteome data by utilizing two-dimensional electrophoresis and mass spectrometry. Then, a mathematical model equation set is constructed for preliminary analysis, a protein interaction network is optimized through an embedded game optimization index model, and feature extraction and quantitative analysis are conducted through a convolution parameter adaptive function and a residual network deep learning model; finally, a quantitative analysis result containing the protein expression level and the function importance is generated in combination with the multi-dimensional protein expression contribution index, and the technical problem that in the prior art, in the rapid quantitative analysis process of the outer vesicle proteome, the protein component complexity is high, and consequently the quantitative precision is low is solved.

The invention relates to the field of agricultural products, and particularly discloses a polypeptide for improving plant disease resistance, and the polypeptide is LAND2 small peptide and homologous peptide thereof. The LAND2 small peptide disclosed by the invention is screened and found from an arabidopsis thaliana proteome, and homologous peptides of the LAND2 small peptide are respectively derived from chilies and cucumbers. Tests prove that when the LAND2 small peptide is externally applied to arabidopsis thaliana, the local and systematic resistance of plants to botrytis cinerea can be enhanced, and the LAND2 small peptide has broad-spectrum immunocompetence in chilies and cucumbers. The polypeptide is practically applied to agricultural production, can enhance the disease resistance of plants and improve the yield and quality of the plants, and has practical popularization and application values.

The present invention relates to nucleic acids coding for a protein said protein comprising a truncated glial fibrillary acidic protein (GFAP), proteins comprising a truncated GFAP, expression constructs comprising a nucleic acid coding for a protein which comprises a truncated GFAP, vectors comprising the nucleic acids or expression constructs disclosed herein and eukaryotic cells comprising a nucleic acid, proteins, expression construct or vector disclosed herein. The present invention furthermore relates to compositions comprising the herein disclosed proteins and kits comprising the herein disclosed proteins and / or compositions. Furthermore, the present invention relates to the use of the herein disclosed proteins, compositions and / or kits for calibrating a measurement system for the in vitro quantification of GFAP or a variant thereof in a sample.

According to the screening method for the potential protein biomarkers and the drug targets of the gastric cancer, Mendel randomization analysis in a proteome range is adopted, the genetic causal relationship between circulating plasma protein and the risk of the gastric cancer is evaluated, and finally the remarkably related protein is identified. According to the screening method of the potential protein biomarker and the drug target of the gastric cancer, provided by the invention, the potential association between circulating plasma protein and the gastric cancer is systematically revealed by integrating Mendel randomization, single-cell RNA sequencing analysis, space transcriptome analysis, virtual drug screening, molecular docking, molecular dynamics simulation and other methods.

This disclosure pertains to compositions comprising an anti-FcRn antibody, M281. The compositions include the full, intact antibody and size variants thereof that not include two antibody heavy chains and to antibody light chains. Thus, a M281 pharmaceutical composition can include: an antibody comprising a heavy chain comprising the amino acid sequence of SEQ ID NO:2 and a light chain comprising the amino acid sequence of SEQ ID NO:1, wherein the composition comprises a major protein component having a molecular weight of 140,000-145,000 Da and a minor protein component of molecular weight 118,000-120,000 Da.

The presently described and claimed disclosure relates to capillary electrophoresis methods for quantifying an intact AAV genome and protein components in an AAV using the same capillary electrophoresis system. The claimed and described approach offers an automated analysis of AAV samples and provides information to determine the AAV empty / full ratio.

The present application relates to a kind of anaphalis contorta exosome extraction method and its application.The exosome is obtained by ultra-high speed centrifugation method from fresh anaphalis contorta, particle size is 160-200 nm, Zeta potential is-21.63±1.34 mV, with double membrane structure, mainly containing protein (such as resveratrol O-methyltransferase etc.) and phospholipid, polysaccharide content is only 12.5% of anaphalis contorta fresh medicine, and does not contain traditional active ingredient anaphalis contorta glycoside.Experiments show that anaphalis contorta exosome can be targeted to enrich in colorectal tissue, significantly improve AOM / DSS induced colorectal cancer model mouse tumor microenvironment, reduce tumor number, regulate T cell and macrophage ratio, and relieve pathological damage, better than anaphalis contorta fresh medicine.The mechanism is related to protein component, not polysaccharide or small molecule component.The anaphalis contorta exosome provided in the present application has simple preparation process, high safety, and has significant anti-colorectal cancer application potential.

The invention relates to the field of aquatic food traceability, in particular to a system for identifying wild and culture sources of bighead carps and application of the system. The system comprises: a sample processing module, wherein the sample processing module is at least used for processing a bighead carp sample to obtain original data of a polypeptide as shown in any one of SEQ ID NO.1-7, and obtaining proteome component response of a to-be-detected sample; the data processing module is at least used for importing the proteome component response of the sample to be detected into an OPLS-DA classification discriminant analysis model to obtain a score plot for discriminant analysis of subsequent sample data; and the result output module is at least used for outputting a result. The system can be effectively used for identifying wild and culture sources of bighead carps, is high in stability and specificity, does not need to use a large instrument, is low in detection cost, and has a wide application prospect in the aspect of aquatic product traceability.

Methods of determining the stoichiometry of a viral capsid and / or determining the heterogeneity of protein components in a viral capsid are described.

The invention discloses an auxiliary protein composition, iron oxide nanoparticles, a preparation method and application, the composition comprises an SC protein with an amino acid sequence as shown in SEQ ID NO: 1 and an ST protein with an amino acid sequence as shown in SEQ ID NO: 2, and the composition can be used for modifying the iron oxide nanoparticles. The auxiliary protein composition can effectively promote endocytosis of the iron oxide nanoparticles, and assists the iron oxide nanoparticles to realize lysosome escape; moreover, the iron oxide nanoparticles modified by the auxiliary protein composition are good in biocompatibility and long in retention and storage time in cells, can be used for long-time labeling of the cells, and have wide clinical transformation and application prospects as a cell tracer agent.

The present invention relates to nucleic acids coding for a protein said protein comprising a glial fibrillary acidic protein (GFAP) and a eukaryotic secretion tag, proteins comprising a GFAP and a eukaryotic secretion tag, expression constructs comprising a nucleic acid coding for a protein which comprises a GFAP and a eukaryotic secretion tag, vectors comprising the nucleic acids or expression constructs disclosed herein and eukaryotic cells comprising a nucleic acid, expression construct or vector disclosed herein. The present invention furthermore relates to methods for the production of the herein disclosed proteins. The present invention also relates to compositions comprising the herein disclosed proteins and kits comprising the herein disclosed proteins and / or compositions. Furthermore, the present invention relates to the use of the herein disclosed proteins, compositions and / or kits for calibrating a measurement system for the in vitro quantification of GFAP or a variant thereof in a sample.

The invention relates to the technical field of organelle separation, and provides a method for rapid purification of peroxisome and oxidation regulation analysis of ultra-long chain fatty acid. The method comprises the following steps: introducing a nucleic acid sequence for coding a fusion protein into a target cell to obtain a cell material, the fusion protein comprising a truncated sequence derived from a peroxisome membrane protein and a tag sequence for affinity purification; taking the cell material as a sample, and separating the peroxisome with the fusion protein from the cell by utilizing an affinity ligand on the basis of a high affinity binding principle. Therefore, according to the method disclosed by the invention, the peroxisome can be rapidly and efficiently enriched, and the whole purification process can be completed within 30 minutes, so that the experimental period is greatly shortened; core protein components of target organelles can be efficiently reserved, and the metabolic activity of peroxisome can be maintained through a complete membrane structure and an internal environment; meanwhile, the same purified sample can synchronously support proteome and metabolome analysis, and direct association of'protein-metabolism 'data is realized.

Described herein is a method of preventing or treating Human Papilloma Virus (HPV) infection in a subject comprising selecting optimal HPV cytotoxic T lymphocyte (CTL) epitopes from an HPV proteome for use in a T cell immunogen composition and methods of administering the composition of subjects infected or at risk of infection with HPV.

The invention belongs to the technical field of proteomics detection, and particularly relates to a method for detecting mouse liver neomembrane proteome based on an orthogonal translation system and a mouse strain containing an SORT-KASM module. Comprising the following steps: (S.1) constructing a conditionally expressed SORT-KASM transgenic mouse strain; (S.2) activating the expression of the SORT-KAS M by a tissue specific Cre system; (S.3) giving unnatural amino acid ingestion to the mouse; and (S.4) carrying out biotin labeling coupling on non-natural amino acids in the proteome through an azide-alkyne click reaction. According to the detection method, the space and time high resolution of the liver tissue is achieved, the membrane protein has the high-coverage marking capacity, the low-abundance newborn protein has the high-sensitivity marking capacity, good stability is achieved, and the membrane protein participates in the important physiological processes such as substance transfer, energy metabolism and steady state maintaining; the innovation of the detection method provides a new thought for researching the liver cell membrane proteome.

A method for constructing a database for discrimination of microorganisms according to the present disclosure includes: a step (S12) for acquiring genome data of two kinds of microorganisms; a step (S14) for predicting a group of proteins produced by each of the two kinds of microorganisms; a step (S16) for producing a list of mass-charge ratios of each of the two kinds of microorganisms; a step (S20) for calculating the degree of similarity between the lists of the mass charge ratios; a step (S32) for generating information that includes the fact that the two kinds of microorganisms cannot be discriminated by MALDI-MS when the degree of similarity is equal to or larger than a predetermined value; and a step (S36) for outputting the information.

The invention relates to the field of aquatic food traceability, in particular to a system for identifying wild and culture sources of grass carps and application of the system. The system comprises: a sample processing module, wherein the sample processing module is at least used for processing a grass carp sample to obtain original data of a polypeptide as shown in any one of SEQ ID NO.1-114, and obtaining proteome component response of a to-be-detected sample; the data processing module is at least used for importing the proteome component response of the sample to be detected into an OPLS-DA classification discriminant analysis model to obtain a score plot for discriminant analysis of subsequent sample data; and the result output module is at least used for outputting a result. The system can be effectively used for identifying wild and culture sources of grass carps, is high in stability and specificity, does not need to use a large instrument, is low in detection cost, and has a wide application prospect in the aspect of aquatic product traceability.

The present disclosure provides devices, systems, and methods related to sequencing a biopolymer. In particular, the present disclosure relates to methods for sequencing a polynucleotide using a bioelectronic device that includes protein assemblies used as coupling molecules in bioelectronic circuits. The present disclosure also provides multimeric protein assemblies with various combinations of live and dead subunits arranged to maximize conduction.

The present invention discloses an EBV-related gastric cancer diagnostic marker and its application, wherein the diagnostic marker is selected from at least one of LF2 protein and BFRF3 protein. The present invention is the first to screen and obtain two diagnostic markers for EBV-related gastric cancer (EBVaGC) based on proteome chips and phage display technology - LF2 protein and BFRF3 protein, which can efficiently and accurately diagnose EBVaGC. In particular, the AUC of the combined diagnosis of these two proteins can reach 0.911, which is significantly better than the AUC of the individual diagnoses. And when diagnosing EBVaGC based on these two proteins, no tissue sample is required, only a serum sample is required, and it can be detected during a routine blood test. Therefore, compared with existing diagnostic methods, the present invention has the characteristics of high accuracy, small limitations, and low cost, reduces the cost of medical treatment for patients, is conducive to the realization of universal screening of the population, simplifies the diagnosis process of EBVaGC, and significantly improves the treatment efficiency.

The invention discloses a microneedle patch for in-vivo space-time omics analysis and a preparation method and application thereof, and belongs to the technical field of gene detection. Comprising the following steps: performing high-density modification on the surface of the microneedle for molecular binding; preparing a micro-needle base grinding tool for constructing a micro-needle patch; connecting the universal primer probe and the capture primer probe to the bar code probe; the microneedle patch captures to-be-detected molecules in a living body in situ; a probe complementary with the strand displacement region is added, polymeric strand displacement is carried out, and the obtained product can be used for constructing a sequencing library to realize spatial omics analysis of a living sample; the microneedle after strand displacement can be coupled with the bar code probe again to realize reuse of the microneedle for a new round of reaction. According to the method, the analysis of the spatial group in the living body sample is realized at extremely low cost, the operation is simple, the application field is wide, and the method can be used for detecting genomes, transcriptomes, proteomes, epigenomes, metabolomes and the like.

The present application belongs to the technical field of protein composition, and relates to a collagen composition and a preparation method thereof. The present application provides a preparation method of a collagen composition, which comprises the following steps: preparing a collagen solution by treating raw hide which has not been subjected to chemical cross-linking treatment; adding a cross-linking promoter, an isothiocyanate and alpha-mammeigin to the collagen solution; and finally obtaining the collagen composition by multiple short-time microwave treatment. The collagen composition provided by the present application avoids the use of a cross-linking agent, has the advantages of no cytotoxicity, high cross-linking degree and good stability, and exhibits excellent antibacterial and antioxidant functions.

The invention provides a CKD early screening marker based on plasma proteomics. The early screening marker comprises the following five kinds of protein: IGFBP4, GDF15, EDA2R, HAVCR1 and XG. The early screening marker provided by the invention can provide ultra-early warning within 16 years before disease attack, is high in prediction accuracy, and is superior to the conventional model in short-term and long-term prediction aspects; meanwhile, a key proteome pathway is disclosed, and reference can be provided for clinical application and prevention strategies. The invention also provides application of the early screening marker based on the CKD.

The invention provides an MASLD early screening marker based on plasma proteomics. The early screening marker comprises the following five proteins: CDHR2, FUOM, KRT18, ACY1 and GGT1. The early screening marker provided by the invention can provide ultra-early warning within 16 years before disease attack, is high in prediction accuracy, and is superior to the conventional model in short-term and long-term prediction aspects; meanwhile, a key proteome pathway is disclosed, and reference can be provided for clinical application and prevention strategies. The invention also provides application of the early screening marker based on the MASLD.

Biomarkers for distinguishing between Chinese honeybee honey and Italian honeybee honey and their applications. Ultra-high performance liquid chromatography-high resolution mass spectrometry (UPLC-TQMS) was used for non-targeted identification and comparative analysis of the animal-derived proteomes of Chinese honeybee honey and Italian honeybee honey. Potential characteristic peptides were screened, and then targeted verification of these potential peptides was performed using UPLC-TQMS. Verification yielded one Chinese honeybee-specific peptide (TVAQSDETLQMIVGMK) and five Italian honeybee-specific peptides (SLPILHEWK, SLNVIHEWK, FFDYDFGSDER, YFDYDFGSEER, and VGDGGPLLQPYPDWSFAK). These specific peptides can serve as molecular markers for distinguishing between Chinese honeybee honey and Italian honey, and can be used for animal-derived honey identification, authenticity determination, and quality control.

The invention relates to the technical field of biological information, and particularly discloses a multi-omics genome combined genetic assessment method and device. According to the method, multi-source data such as a genome, a transcriptome, a proteome, a metabolome, a microbiome and a high-throughput phenotype are integrated by constructing a multi-omics fusion similar matrix, an adaptive dichotomy is adopted to optimize omics weights, a grid search and cross validation system is introduced, and global optimal estimation of parameters is achieved. Verification of the method on livestock and poultry breeding and plant breeding data shows that the prediction accuracy of complex characters can be remarkably improved, and particularly, the prediction precision in low heritability characters is remarkably improved. The invention further provides a corresponding device which comprises a data acquisition module, a matrix construction module, a parameter optimization module and a breeding value calculation module, comprehensive utilization of multi-omics information can be efficiently achieved, and the accuracy and calculation efficiency of breeding value estimation are improved.

The invention relates to the technical field of pathological diagnosis, in particular to a tumor grading detection system based on holoproteome cysteine reactivity analysis, which comprises an in-situ labeling module, an in-situ detection module and an in-situ detection module, the histological separation module is used for carrying out molecular weight layering separation on the labeled tumor protein and counting the fluorescence signal intensity of each layer; the processing and analysis module is used for constructing a proteome-level cysteine reactivity map with position resolution capability; the tumor grading module is used for carrying out normalization processing on the average fluorescence intensity of each layer and the highest signal layer to obtain normalized intensity T, drawing a component specificity risk curve by taking the number of layers as a horizontal coordinate, and recording the area under the curve as the normalized intensity T as TSI; the TSI is in positive correlation with the tumor malignancy degree and serves as the basis of tumor grading. The method can accurately diagnose a tumor positive area, and the specificity and the sensitivity are both 100%.

The invention discloses a gene level DNA methylation, transcriptome and proteome conjoint analysis method based on a snkemake framework, which comprises the following steps: preprocessing original data of DNA methylation and / or transcriptome and / or proteome, analyzing gene methylation, analyzing transcriptome and / or proteome, and analyzing the transcriptome and proteome. Based on gene methylation analysis data, the preprocessed transcriptome data and the preprocessed proteome data, correlation analysis and / or difference intersection analysis and / or enrichment pathway conjoint analysis are / is carried out, finally analysis results are sorted, and a visual report is generated. The method has comprehensive results, and relates to quantification, difference analysis and pathway enrichment analysis of gene methylation, and correlation analysis, difference intersection analysis and enrichment pathway joint analysis of integrated DNA methylation and / or transcriptome and / or proteome data; automatic arrangement, verification, visualization and report generation of analysis results are realized; all operation steps can be traced, and corresponding analysis log records are generated. The invention further discloses a related system and application.

To provide a combination of proteins that contains a TlpA mutant and can induce substance interaction by heating.SOLUTION: A protein set for inducing substance interaction in a temperature-dependent manner comprises: a protein set comprising a protein having a binding-inducing peptide bound to the N-terminus or C-terminus of the following protein a, the following protein b, and the binding-inducing protein; or a protein set comprising a protein having a binding-inducing peptide bound to the N-terminus or C-terminus of the following protein b, the following protein a, and the binding-inducing protein; a: a protein comprising the whole or a part of a coiled-coil region of a protein having a specific amino acid sequence, and having mutations indicated by E180R and E250R; and b: a protein comprising the whole or a part of a coiled-coil region of a protein having the specific amino acid sequence and having mutations indicated by R179E and R251E.SELECTED DRAWING: None

The present invention relates to a method for producing immunogenic compositions, such as vaccines, by identifying amino acid sequence of antigenic patches (Ag-Patches) from at least one proteome of a pathogen, derived from overlapping epitope clusters. In particular, the invention relates to the design of Multi-Patch Vaccines against viral, such as SARS-CoV-2, bacterial, fungi, parasite, pathogenic and non-pathogenic targets.